weight loss response to semaglutide in postmenopausal women Zepbound vs. vs. Wegovy: What's the Difference? Should postmenopausal women use injectable

Oral semaglutide has previously been shown to reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease, chronic kidney disease or both in the SOUL trial (McGuire et al, 2025)

Am I eligible for discounts or savings programs to help with out-of-pocket costs

These sites have been specifically validated through clinical trials to ensure consistent drug absorption, with no clinically meaningful differences in exposure observed between injection sites

Never adjust your dose without speaking to a healthcare provider, but remember, slowing titration is a common and practical option

Continue your regular dosing schedule for future injections and contact your healthcare provider if you experience unusual symptoms or have concerns about your injection technique